Company News

  • Leaders of Yuhang District visited Testsea Bio

    Leaders of Yuhang District visited Testsea Bio

    On the morning of December 6, Tang Liyu, member of the Standing Committee of the Yuhang District Committee of Hangzhou City, Zhejiang Province, and Secretary of the Party Committee of Pingyao Town, and Yao Wenhua, deputy head of the People’s Government of Yuhang District, Hangzhou City, Zhejiang...
    Read more
  • Company statement on Virus mutation.

    Company statement on Virus mutation.

    According to the latest research,there are many mutant strains of the Covid-19 virus which are the British variants (VOC202012/01,B.1.1.7 or 20B/50YV1). There are 4 mutation points on the nucleocapsid protein,which are located at D3L,R203K,G203R andS235FSouth Africa vari...
    Read more
  • Testsealabs COVID-19 Antigen Rapid Test can effectively cover coronavirus Omicron (B.1.1529) variant strain

    Testsealabs COVID-19 Antigen Rapid Test can effectively cover coronavirus Omicron (B.1.1529) variant strain

    At present, our company conducts detailed comparison and analysis based on the nucleic acid sequence of the mutation site of the Omicron mutant strain published by the GISAID database and the recognition epitope of the specific anti-N protein antibody used in our Coronav...
    Read more
  • The Coronavuris is coming to an end

    The Coronavuris is coming to an end

    Coronavuris treatment drugs are coming to provide treatment support for infected patients. The launch of Merck and Pfizer’s COVID-19 drugs gives people the opportunity to choose specific drugs after being infected with the coronavuris, and psychologically they no longer have to worry about ...
    Read more
  • Pfizer’s new crown oral medicine is effective, and the price is not cheap!

    Pfizer’s new crown oral medicine is effective, and the price is not cheap!

    Judging from the current situation, what happened during the vaccine distribution process is likely to be repeated on the new crown oral medicine. On Friday, local time, the global pharmaceutical leader Pfizer announced that its protease inhibitor PF-07321332 and the antiviral drug Ritonavir (col...
    Read more